)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Harmony Biosciences
Harmony Biosciences (HRMY) investor relations material
Harmony Biosciences Piper Sandler Virtual CNS Symposium summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Piper Sandler Virtual CNS Symposium summary13 Aug, 2026
Key financial and product performance highlights
Achieved record quarterly performance for WAKIX, supporting pipeline development and business transactions.
Strong WAKIX sales enable advancement of BP-205 and other pipeline products.
Commercial execution and team capabilities highlighted as drivers of growth.
BP-205 clinical development and outlook
BP-205 features a novel, highly potent orexin 2 receptor agonist scaffold with favorable safety profile.
Single ascending dose study showed rapid onset, dose proportionality, long half-life, and no major safety concerns.
MAD study completed; insomnia and polyuria observed but not severe; full data expected Q4.
IND opened in the US; sleep-deprived volunteer study to start, with top-line data in early 2027.
Multiple phase II studies planned for CNS indications, targeting cognition, attention, mood, and fatigue.
Orexin agonist portfolio strategy
Intends to build a broad orexin agonist portfolio for both rare and large CNS indications.
Plans to differentiate assets by indication and market needs, with backup compounds in development.
Timelines for additional orexin compounds not yet disclosed.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Harmony Biosciences
- Q2 2026 revenue up 30% to $261.3M, with strong WAKIX growth and pipeline advancement.HRMY
Q2 2026 - Four-pillar strategy drives WAKIX growth, orexin pipeline, and targeted business development.HRMYGoldman Sachs 47th Annual Global Healthcare Conference 2026
- Directors were elected, auditor ratified, and executive pay approved, with Q&A held.HRMYAGM 2026
- Q1 2026 revenue up 17% to $215.4M; full-year guidance reaffirmed at $1.0–$1.04B.HRMYQ1 2026
- WAKIX momentum, pipeline innovation, and strategic BD drive growth and CNS leadership.HRMY25th Annual Needham Virtual Healthcare Conference
- Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.HRMYProxy filing
- 2025 revenue up 22% year-over-year; 2026 WAKIX guidance set at $1.0–$1.04B.HRMYQ4 2025
- Q1 2025 revenue up 20% to $184.7M, net income $45.6M, and 2025 guidance reaffirmed.HRMYQ1 2025
- 2024 revenue up 23% to $714.7M, with strong WAKIX sales and robust 2025 growth outlook.HRMYQ4 2024
Next Harmony Biosciences earnings date
Q3 20263 Nov, 2026
Harmony Biosciences
Next Harmony Biosciences earnings date
Q3 20263 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage